+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Automated Insulin Delivery System Market Research Report by Disease Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4858013
  • Report
  • July 2021
  • Region: Global
  • 181 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Automated Insulin Delivery System Market will Grow to USD 1,085.19 Million by 2026, at a CAGR of 9.59%

FEATURED COMPANIES

  • Abbott Laboratories
  • Bigfoot Biomedical Inc.
  • Companion Medical
  • Diabeloop SA
  • DreaMed Diabetes Ltd
  • Eli Lilly and Company
  • MORE
The Global Automated Insulin Delivery System Market size was estimated at USD 626.16 Million in 2020 and expected to reach USD 684.15 Million in 2021, at a Compound Annual Growth Rate (CAGR) 9.59% to reach USD 1,085.19 Million by 2026.



Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Automated Insulin Delivery System to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Disease Type, the Automated Insulin Delivery System Market was examined across Type I Diabetes and Type II Diabetes.
  • Based on Distribution, the Automated Insulin Delivery System Market was examined across Diabetes Clinics, Hospital Pharmacies, and Retail Pharmacies.
  • Based on Geography, the Automated Insulin Delivery System Market was examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas was further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific was further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa was further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies this research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Automated Insulin Delivery System Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Automated Insulin Delivery System Market, including Abbott Laboratories, BD, Animas LLC, Bigfoot Biomedical Inc., Biocon, Companion Medical, Dexcom, Inc., Diabeloop SA, Digital Medics,, DreaMed Diabetes Ltd, DRF International,, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Insulet Corporation, Medtronic PLC, Novo Nordisk A/S, Sanofi S.A., Tandem Diabetes Care, Inc., and Ypsomed Holding AG.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Automated Insulin Delivery System Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Automated Insulin Delivery System Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Automated Insulin Delivery System Market?
4. What is the competitive strategic window for opportunities in the Global Automated Insulin Delivery System Market?
5. What are the technology trends and regulatory frameworks in the Global Automated Insulin Delivery System Market?
6. What is the market share of the leading vendors in the Global Automated Insulin Delivery System Market?
7. What modes and strategic moves are considered suitable for entering the Global Automated Insulin Delivery System Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Bigfoot Biomedical Inc.
  • Companion Medical
  • Diabeloop SA
  • DreaMed Diabetes Ltd
  • Eli Lilly and Company
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Disease Type Outlook
3.4. Distribution Outlook
3.5. Geography Outlook
3.6. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of diabetes
5.1.1.2. Increasing awareness campaigns
5.1.1.3. High investment in R&D for new technology and automation in medical devices
5.1.2. Restraints
5.1.2.1. Difficulties with the calibration of a glucose sensor, sensor durability, skin-related issues
5.1.3. Opportunities
5.1.3.1. Increasing R&D activities for the production of innovative insulin delivery systems
5.1.3.2. Mild regulatory approval and technical clarity for the use of devices among people
5.1.4. Challenges
5.1.4.1. Limited awareness and reach in developing economies
5.1.4.2. Challenges such as pump imprecision and sensor inaccuracy or unreliability
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Automated Insulin Delivery System Market, by Disease Type
6.1. Introduction
6.2. Type I Diabetes
6.3. Type II Diabetes

7. Automated Insulin Delivery System Market, by Distribution
7.1. Introduction
7.2. Diabetes Clinics
7.3. Hospital Pharmacies
7.4. Retail Pharmacies

8. Americas Automated Insulin Delivery System Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Automated Insulin Delivery System Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Thailand

10. Europe, Middle East & Africa Automated Insulin Delivery System Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Abbott Laboratories
12.2. BD, Animas LLC
12.3. Bigfoot Biomedical Inc.
12.4. Biocon
12.5. Companion Medical
12.6. Dexcom, Inc.
12.7. Diabeloop SA
12.8. Digital Medics,
12.9. DreaMed Diabetes Ltd
12.10. DRF International,
12.11. Eli Lilly and Company
12.12. F. Hoffmann-La Roche Ltd
12.13. Insulet Corporation
12.14. Medtronic PLC
12.15. Novo Nordisk A/S
12.16. Sanofi S.A.
12.17. Tandem Diabetes Care, Inc.
12.18. Ypsomed Holding AG

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2020 (USD MILLION)
FIGURE 3. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2020 (USD MILLION)
FIGURE 4. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 5. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 6. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: MARKET DYNAMICS
FIGURE 7. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 8. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2020 VS 2026 (%)
FIGURE 9. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2026
FIGURE 11. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE I DIABETES, 2018-2026 (USD MILLION)
FIGURE 12. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE I DIABETES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 13. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE II DIABETES, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE II DIABETES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2020 VS 2026 (%)
FIGURE 16. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2020 VS 2026 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2026
FIGURE 18. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DIABETES CLINICS, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DIABETES CLINICS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2026 (USD MILLION)
FIGURE 21. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 22. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2026 (USD MILLION)
FIGURE 23. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 24. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 25. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 27. ARGENTINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 28. BRAZIL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 29. CANADA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 30. MEXICO AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 31. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 32. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 33. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 35. AUSTRALIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 36. CHINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 37. INDIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 38. INDONESIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 39. JAPAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 40. MALAYSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 41. PHILIPPINES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 42. SINGAPORE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 43. SOUTH KOREA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 44. THAILAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 45. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 46. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 48. FRANCE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 49. GERMANY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 50. ITALY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 51. NETHERLANDS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 52. QATAR AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 53. RUSSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 54. SAUDI ARABIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 55. SOUTH AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 56. SPAIN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 57. UNITED ARAB EMIRATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 58. UNITED KINGDOM AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 59. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: FPNV POSITIONING MATRIX
FIGURE 60. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 61. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE I DIABETES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE II DIABETES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DIABETES CLINICS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 11. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 12. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 13. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 14. ARGENTINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 15. ARGENTINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 16. BRAZIL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 17. BRAZIL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 18. CANADA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 19. CANADA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 20. MEXICO AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 21. MEXICO AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 22. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 23. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 24. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 25. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 26. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 27. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 28. AUSTRALIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 29. AUSTRALIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 30. CHINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 31. CHINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 32. INDIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 33. INDIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 34. INDONESIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 35. INDONESIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 36. JAPAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 37. JAPAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 38. MALAYSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 39. MALAYSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 40. PHILIPPINES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 41. PHILIPPINES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 42. SINGAPORE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 43. SINGAPORE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 44. SOUTH KOREA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 45. SOUTH KOREA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 46. THAILAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 47. THAILAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 48. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 51. FRANCE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 52. FRANCE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 53. GERMANY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 54. GERMANY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 55. ITALY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 56. ITALY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 57. NETHERLANDS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 58. NETHERLANDS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 59. QATAR AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 60. QATAR AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 61. RUSSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 62. RUSSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 63. SAUDI ARABIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 64. SAUDI ARABIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 65. SOUTH AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 66. SOUTH AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 67. SPAIN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 68. SPAIN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 69. UNITED ARAB EMIRATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 70. UNITED ARAB EMIRATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 71. UNITED KINGDOM AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 72. UNITED KINGDOM AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 73. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: SCORES
TABLE 74. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: BUSINESS STRATEGY
TABLE 75. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: PRODUCT SATISFACTION
TABLE 76. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: RANKING
TABLE 77. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 78. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: MERGER & ACQUISITION
TABLE 79. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 80. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 81. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: INVESTMENT & FUNDING
TABLE 82. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 83. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • BD, Animas LLC
  • Bigfoot Biomedical Inc.
  • Biocon
  • Companion Medical
  • Dexcom, Inc.
  • Diabeloop SA
  • Digital Medics,
  • DreaMed Diabetes Ltd
  • DRF International,
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Insulet Corporation
  • Medtronic PLC
  • Novo Nordisk A/S
  • Sanofi S.A.
  • Tandem Diabetes Care, Inc.
  • Ypsomed Holding AG
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll